Cite
Lymphopenia confers poorer prognosis in Myelodysplastic Syndromes with very low and low IPSS-M.
MLA
Fandrei, David, et al. “Lymphopenia Confers Poorer Prognosis in Myelodysplastic Syndromes with Very Low and Low IPSS-M.” Blood Cancer Journal, vol. 13, no. 1, Dec. 2023, p. 193. EBSCOhost, https://doi.org/10.1038/s41408-023-00965-w.
APA
Fandrei, D., Huynh, T., Sébert, M., Aguinaga, L., Bisio, V., Kim, R., Clappier, E., Espéli, M., Balabanian, K., Moins-Teisserenc, H., Toubert, A., Dulphy, N., Fenaux, P., Adès, L., & Zhao, L.-P. (2023). Lymphopenia confers poorer prognosis in Myelodysplastic Syndromes with very low and low IPSS-M. Blood Cancer Journal, 13(1), 193. https://doi.org/10.1038/s41408-023-00965-w
Chicago
Fandrei, David, Tony Huynh, Marie Sébert, Lorea Aguinaga, Valeria Bisio, Rathana Kim, Emmanuelle Clappier, et al. 2023. “Lymphopenia Confers Poorer Prognosis in Myelodysplastic Syndromes with Very Low and Low IPSS-M.” Blood Cancer Journal 13 (1): 193. doi:10.1038/s41408-023-00965-w.